[Federal Register Volume 68, Number 105 (Monday, June 2, 2003)]
[Notices]
[Pages 32756-32757]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-13653]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel: Active Surveillance for Pertussis--Surveillance for 
Vaccine Preventable Disease as a Foundation for Evaluating the 
Effectiveness and Impact of an Adolescent/Adult Pertussis Immunization 
Program and for Evaluating the Feasibility of a Pediatric Hospital-
Based Sentinel Surveillance Network for Vaccine Preventable Diseases, 
Program Announcement 03101 and Solicitation 2003-N-0837

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease

[[Page 32757]]

Control and Prevention (CDC) announces the following meeting:
    Name: Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP): Active Surveillance for Pertussis-
Surveillance for Vaccine Preventable Disease as a Foundation for 
Evaluating the Effectiveness and Impact of an Adolescent/Adult 
Pertussis Immunization Program and for Evaluating the Feasibility of a 
Pediatric Hospital-Based Sentinel Surveillance Network for Vaccine 
Preventable Diseases, Program Announcement 03101 and 
Solicitation 2003-N-0837.
    Times and Dates: 6 p.m.-7 p.m., June 26, 2003. (Open) 7 p.m.-9 
p.m., June 26, 2003. (Closed) 8 a.m.-4:30 p.m., June 27, 2003. (Closed)
    Place: Doubletree Hotel, 3342 Peachtree Road, NE., Atlanta, GA 
30326, Telephone 404.231.1234.
    Status: Portions of the meeting will be closed to the public in 
accordance with provisions set forth in section 552b(c) (4) and (6), 
Title 5 U.S.C., and the Determination of the Director, Management 
Analysis and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
Program Announcement 03101 and Solicitation 2003-N-0837.

FOR FURTHER INFORMATION CONTACT: Kim Lane, Associate Director for 
Management and Operations, National Immunization Program, CDC, 1600 
Clifton Road, NE., MS-E05, Atlanta, GA 30333, Telephone 404--639-8201.
    The Director, Management Analysis and Services Office has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

    Dated: May 27, 2003.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 03-13653 Filed 5-30-03; 8:45 am]
BILLING CODE 4163-18-P